Related Experiment Videos
Small-molecule kinase-inhibitor target assessment
1Chemistry and Chemical Biology Graduate Program, University of California, San Francisco, CA 94143, USA.
Chembiochem : a European Journal of Chemical Biology
|February 8, 2005
Summary
Identifying cellular targets for protein kinase inhibitors is crucial for drug development. This review covers biochemical, genetic, and chemical-genomics methods for target identification and validation, aiding therapeutic assessment.
Area of Science:
- Biochemistry
- Genetics
- Pharmacology
Background:
- Identifying cellular targets of small-molecule protein kinase inhibitors presents a significant challenge in evaluating their therapeutic potential for various diseases.
- Protein kinases are crucial in cell signaling, and their dysregulation is implicated in numerous pathologies, making them key drug targets.
Purpose of the Study:
- To review existing biochemical and genetics-based approaches for identifying protein kinase inhibitor targets.
- To describe a novel chemical-genomics approach for kinase-inhibitor target identification and validation.
Main Methods:
- Review of established biochemical and genetic methodologies for target identification.
- Description of a chemical-genomics strategy involving the matching of transcriptional signatures.
Main Results:
- The study outlines diverse strategies for identifying inhibitor targets.
- A chemical-genomics approach is detailed, utilizing transcriptional profiling to link drug effects to specific kinase targets.
Conclusions:
- Accurate identification and validation of kinase inhibitor targets are essential for drug development.
- The chemical-genomics approach offers a powerful tool for understanding drug specificity and validating therapeutic targets in disease contexts.